Stay updated on ABT-493/ABT-530 in Genotype 2 Hepatitis C Clinical Trial
Sign up to get notified when there's something new on the ABT-493/ABT-530 in Genotype 2 Hepatitis C Clinical Trial page.

Latest updates to the ABT-493/ABT-530 in Genotype 2 Hepatitis C Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedFooter revision updated from v3.3.1 to v3.3.2. No study data or page content was altered.SummaryDifference0.1%

- Check21 days agoChange DetectedPublication notes were updated to indicate that publications are automatically filled from PubMed and may not be about the study. The revision label changed from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoval of the government funding/operating status notice from the page. Core study information such as eligibility criteria, endpoints, and study results remains unchanged.SummaryDifference0.4%

- Check43 days agoChange DetectedNo additions or deletions were detected on the page. The study details and layout appear unchanged.SummaryDifference0.3%

- Check71 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.SummaryDifference3%

- Check79 days agoChange DetectedReleased a new version: v3.1.0, replacing the old v3.0.2. This is a version upgrade with potential feature/bug fix implications.SummaryDifference0.1%

Stay in the know with updates to ABT-493/ABT-530 in Genotype 2 Hepatitis C Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABT-493/ABT-530 in Genotype 2 Hepatitis C Clinical Trial page.